Anti-B3GN9/ B3GNT9 functional antibody

Anti-B3GN9/ B3GNT9 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to B3GNT9/B3GNT9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1664-Ab-1/ GM-Tg-hg-SE1664-Ab-2Anti-Human B3GNT9 monoclonal antibodyHuman
GM-Tg-rg-SE1664-Ab-1/ GM-Tg-rg-SE1664-Ab-2Anti-Rat B3GNT9 monoclonal antibodyRat
GM-Tg-mg-SE1664-Ab-1/ GM-Tg-mg-SE1664-Ab-2Anti-Mouse B3GNT9 monoclonal antibodyMouse
GM-Tg-cynog-SE1664-Ab-1/ GM-Tg-cynog-SE1664-Ab-2Anti-Cynomolgus/ Rhesus macaque B3GNT9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1664-Ab-1/ GM-Tg-felg-SE1664-Ab-2Anti-Feline B3GNT9 monoclonal antibodyFeline
GM-Tg-cang-SE1664-Ab-1/ GM-Tg-cang-SE1664-Ab-2Anti-Canine B3GNT9 monoclonal antibodyCanine
GM-Tg-bovg-SE1664-Ab-1/ GM-Tg-bovg-SE1664-Ab-2Anti-Bovine B3GNT9 monoclonal antibodyBovine
GM-Tg-equg-SE1664-Ab-1/ GM-Tg-equg-SE1664-Ab-2Anti-Equine B3GNT9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1664-Ab-1/ GM-Tg-hg-SE1664-Ab-2; GM-Tg-rg-SE1664-Ab-1/ GM-Tg-rg-SE1664-Ab-2;
GM-Tg-mg-SE1664-Ab-1/ GM-Tg-mg-SE1664-Ab-2; GM-Tg-cynog-SE1664-Ab-1/ GM-Tg-cynog-SE1664-Ab-2;
GM-Tg-felg-SE1664-Ab-1/ GM-Tg-felg-SE1664-Ab-2; GM-Tg-cang-SE1664-Ab-1/ GM-Tg-cang-SE1664-Ab-2;
GM-Tg-bovg-SE1664-Ab-1/ GM-Tg-bovg-SE1664-Ab-2; GM-Tg-equg-SE1664-Ab-1/ GM-Tg-equg-SE1664-Ab-2
Products NameAnti-B3GNT9 monoclonal antibody
Formatmab
Target NameB3GNT9
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-B3GNT9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1664-Ag-1Recombinant multi-species B3GN9/ B3GNT9 protein


    Target information

    Target IDGM-SE1664
    Target NameB3GNT9
    Gene ID84752,97440,291958,698037,489767,101097530,614717,100065795
    Gene Symbol and Synonyms3-Gn-T9,B3GNT9,B3gnt9-ps,beta-1,beta3Gn-T9,BGnT-9,RGD1310170
    Uniprot AccessionQ6UX72,Q17QZ8
    Uniprot Entry NameB3GN9_HUMAN,B3GN9_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000237172
    Target ClassificationN/A

    The target: B3GNT9, gene name: B3GNT9, also named as . Predicted to enable UDP-glycosyltransferase activity. Predicted to be involved in poly-N-acetyllactosamine biosynthetic process. Predicted to be integral component of membrane. Predicted to be active in Golgi membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.